Belumosudil for chronic graft-versus-host disease after 2 or more …
https://ashpublications.org/blood/article/138/22/2278/476399/Belumosudil-for-chronic-graft-versus-host-disease
WEBDec 2, 2021 · Despite first-line therapy for National Institutes of Health (NIH)-defined moderate to severe cGVHD with systemic corticosteroids (CSs) alone or in combination with sirolimus or a calcineurin inhibitor (CNI), 16,17 ≥70% of patients require subsequent lines of therapy (LOTs) owing to the toxicity and the lack of efficacy associated with current …
DA: 49 PA: 28 MOZ Rank: 41